Insights On Trial Design

  1. Vendor Selection Bias: Why Structured Decisions Often Fail 12/22/2025

    Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.

  2. Recruitment Strategies For Faster Enrollment And Reliable Results 5/14/2025

    This presentation highlights recruitment strategies that lead to faster enrollment timelines, optimized budgets, and consistently reliable results.

  3. Recap – Optimizing Pediatric Trials To Generate High-Quality Data 3/20/2024

    In pediatric trials, leading pediatric clinical research expert Dr. Joan Busner explains that age and cognitive differences make COA measurement more complex and harder to standardize.

  4. Planning For High-Performance Hematologic Oncology Clinical Trials 5/7/2024

    Running successful clinical trials in hematologic malignancies necessitates a deep comprehension of a swiftly evolving treatment framework that is growing more nuanced, intricate, and patient-centered.

  5. Choosing The Most Effective Method For Biopharmaceutical Development 5/2/2025

    Explore how the application of protein assays extend from basic research to the development of cutting-edge therapies, which makes them indispensable in the quest to improve human health.

  6. Can Mobile Visits Attract And Keep More Children In Clinical Trials? 4/8/2024

    As sponsors face regulatory pressure to include more pediatric patients in trials, could mobile nurse visits help them enroll more patients from this underrepresented group?

  7. Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study 12/20/2024

    This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.

  8. Advancing Clinical Research In 2025: Meeting FDA Standards In DCT 1/22/2025

    Explore the key components of new FDA guidance on DCTs, including a focus on participant-centric designs and the use of Mobile Research Units (MRUs) to overcome geographic and technological barriers.

  9. The Impact Of High Inflation And The Great Resignation On Clinical Site Budgeting 10/30/2024

    The twin pressures of inflation and attrition prolong negotiations between sponsors and clinical sites, stalling drug development. Sponsors need up-to-date, reliable benchmark data to negotiate fair market value budgets.

  10. A 2025 Survey Report Uncovers The Top 5 Clinical Trial Cost Insights 4/22/2025

    In this 2025 survey of over 100 U.S. clinical trial participants and caregivers, we reveal that most individuals join trials seeking life-saving treatment, not financial gain.